Artificial intelligence is here, and it’s here to stay and the number of companies developing AI technologies for radiology applications is increasing rapidly. More than 40 companies now have at least one FDA-cleared product, with multiple solutions available for brain, breast, cardiac, lung, liver and MSK applications. In terms of industry maturity, medical imaging and diagnostics is identified as one of only a handful that score highly, both in terms of AI industry adoption and market strength¹.

 

Click here to download the full whitepaper